Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase-Reference-Cited by-同舟云学术

Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase

Author:

Mahé Julien¹^ORCID,de Campaigno Emilie Patras²³,Chené Anne-Laure⁴,Montastruc Jean-Louis²³⁵⁶^ORCID,Despas Fabien²³⁵⁷,Jolliet Pascale¹⁸

Affiliation:

1. Service de Pharmacologie Clinique; CHU de Nantes; Nantes France

2. Service de Pharmacologie Médicale et Clinique; CHU de Toulouse; Toulouse France

3. UMR1027, Inserm; Université Paul Sabatier; Toulouse France

4. Institut du thorax, hôpital CHU de Nantes; Nantes France

5. Service de Pharmacologie Médicale et Clinique, Faculté de Médecine; Université Paul Sabatier; Toulouse France

6. Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament; CHU de Toulouse; Toulouse France

7. INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse; CHU de Toulouse; France

8. UMR INSERM 1246 - SPHERE MethodS in Patients-centered outcomes and HEalth ResEarch

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference55 articles.

5. C-kit, GIST, and imatinib;Siehl;Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献